These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 25195064)

  • 1. L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial.
    Zeinoddini A; Ahadi M; Farokhnia M; Rezaei F; Tabrizi M; Akhondzadeh S
    J Psychiatr Res; 2014 Dec; 59():125-31. PubMed ID: 25227564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems.
    Maia-de-Oliveira JP; Lobão-Soares B; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2014 Nov; 159(2-3):558-9. PubMed ID: 25223842
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.
    Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M
    Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restructuring consciousness -the psychedelic state in light of integrated information theory.
    Gallimore AR
    Front Hum Neurosci; 2015; 9():346. PubMed ID: 26124719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hunting and hallucinogens: The use psychoactive and other plants to improve the hunting ability of dogs.
    Bennett BC; Alarcón R
    J Ethnopharmacol; 2015 Aug; 171():171-83. PubMed ID: 26027755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.
    Lev-Ran S; Feingold D; Frenkel A; Lerner AG
    J Dual Diagn; 2014; 10(2):79-83. PubMed ID: 25392249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing antipsychotic treatments for schizophrenia: a health state approach.
    Lin LA; Rosenheck R; Sugar C; Zbrozek A
    Psychiatr Q; 2015 Mar; 86(1):107-21. PubMed ID: 25294277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine: is now the time for more clinicians to adopt this orphan?
    Stahl SM
    CNS Spectr; 2014 Aug; 19(4):279-81. PubMed ID: 25267329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition in schizophrenia: Past, present, and future.
    Green MF; Harvey PD
    Schizophr Res Cogn; 2014 Mar; 1(1):e1-e9. PubMed ID: 25254156
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging drugs for schizophrenia: an update.
    Köster LS; Carbon M; Correll CU
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):511-31. PubMed ID: 25234340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology.
    Buda O; Hostiuc S; Popa-Velea O; Boroghina S
    Front Pharmacol; 2022; 13():1053534. PubMed ID: 36561338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment.
    Brierley DI; Davidson C
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):263-72. PubMed ID: 22691716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.
    Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F
    J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333
    [No Abstract]   [Full Text] [Related]  

  • 14. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
    López-Muñoz F; Alamo C; Juckel G; Assion HJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120
    [No Abstract]   [Full Text] [Related]  

  • 15. "Rational hope" in the early treatment of Parkinson's disease.
    Sourkes TL
    Can J Physiol Pharmacol; 1999 Jun; 77(6):375-82. PubMed ID: 10537223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmine for catatonic schizophrenia. A forgotten experiment.
    Hostiuc S; Buda O; Ion DA
    Schizophr Res; 2014 Oct; 159(1):249-50. PubMed ID: 25195064
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychiatry in traditional song: catatonic schizophrenia.
    Campbell GD; Daynes WG
    Adler Mus Bull; 1997 Jul; 23(2):18-9. PubMed ID: 11619484
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.